SNCA and Parkinson disease: Although there is no definite evidence that α-synuclein is absolutely essential and the only relevant pathogen for the development of neurodegeneration or clinical parkinsonism [31], the potential contribution of α-synuclein is evidenced by above mentioned preclinical studies and clinical observations that SNCA multiplications cause familiar PD [32].